Your browser doesn't support javascript.
loading
Intratumoral Heterogeneity and Immune Response Indicators to Predict Overall Survival in a Retrospective Study of HER2-Borderline (IHC 2+) Breast Cancer Patients.
Radziuviene, Gedmante; Rasmusson, Allan; Augulis, Renaldas; Grineviciute, Ruta Barbora; Zilenaite, Dovile; Laurinaviciene, Aida; Ostapenko, Valerijus; Laurinavicius, Arvydas.
Afiliación
  • Radziuviene G; National Center of Pathology, Affiliate of Vilnius University Hospital Santaros Clinics, Vilnius, Lithuania.
  • Rasmusson A; Institute of Biosciences, Life Sciences Center, Vilnius University, Vilnius, Lithuania.
  • Augulis R; National Center of Pathology, Affiliate of Vilnius University Hospital Santaros Clinics, Vilnius, Lithuania.
  • Grineviciute RB; Faculty of Medicine, Institute of Biomedical Sciences, Vilnius University, Vilnius, Lithuania.
  • Zilenaite D; National Center of Pathology, Affiliate of Vilnius University Hospital Santaros Clinics, Vilnius, Lithuania.
  • Laurinaviciene A; Faculty of Medicine, Institute of Biomedical Sciences, Vilnius University, Vilnius, Lithuania.
  • Ostapenko V; National Center of Pathology, Affiliate of Vilnius University Hospital Santaros Clinics, Vilnius, Lithuania.
  • Laurinavicius A; National Center of Pathology, Affiliate of Vilnius University Hospital Santaros Clinics, Vilnius, Lithuania.
Front Oncol ; 11: 774088, 2021.
Article en En | MEDLINE | ID: mdl-34858854
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: Lituania Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: Lituania Pais de publicación: Suiza